Cannabidiol, also know as CBD, is discontinued (DEA controlled substance). It is a major phytocannabinoid, accounting for up to 40% of the plant's extract. CBD is considered to have a wider scope of potential medical applications than tetrahydrocannabinol (THC). Cannabidiol has been listed in the European Commission Cosmetics Ingredient Database with four functional claims: antioxidant, antiseborroeic, skin conditioning, and skin protecting
Shultz, Zachary P.; Lawrence, Grant A.; Jacobson, Jeffrey M.; Cruz, Emmanuel J.; Leahy, James W. Enantioselective Total Synthesis of Cannabinoids-A Route for Analogue Development. Organic Letters. Volume 20. Issue 2. Pages 381-384. Journal; Online Computer File. (2018).
Vaillancourt, Valerie; Albizati, Kim F. A one-step method for the α-arylation of camphor. Synthesis of (-)-cannabidiol and (-)-cannabidiol dimethyl ether. Journal of Organic Chemistry. Volume 57. Issue 13. Pages 3627-31. Journal. 1992.
Dickman, Daniel; Levin, Daniel. Crystalline form of cannabidiol. Assignee Norac Pharma, USA; S&B Pharma, Inc. US 20170349518. (2017).
Erfurt, Harry; Weber, Maria; Niemeyer, Hans-Juergen; Goetz, Marcus Rudolf; Winkler, Matthias. Method for purifying cannabinoid compounds. Assignee Symrise AG, Germany. WO 2017194173. (2017).
Chen, Jiange; Zhang, Xitong; Wen, Xiaowei; Xu, Changchun. Synthetic method of cannabidiol. Assignee Agno Pharma Tech (Suzhou) Co., Ltd., Peop. Rep. China. CN 106810426. (2017).
Crombie, Leslie; Crombie, W. Mary L.; Jamieson, Sally V.; Palmer, Christopher J. Acid catalyzed terpenylations of olivetol in the synthesis of cannabinoids. Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999). Issue 5. Pages 1243-50. Journal. (1988).
